Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
about
Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH RegistryNew data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials.Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism.Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study".Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
P2860
Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Elevated lipoprotein(a), hyper ...... familial hypercholesterolemia.
@en
type
label
Elevated lipoprotein(a), hyper ...... familial hypercholesterolemia.
@en
prefLabel
Elevated lipoprotein(a), hyper ...... familial hypercholesterolemia.
@en
P2093
P50
P1476
Elevated lipoprotein(a), hyper ...... familial hypercholesterolemia
@en
P2093
Amanda J Hooper
Damon A Bell
Frank M van Bockxmeer
John R Burnett
Timothy R Bates
P304
P356
10.1016/J.IJCARD.2015.08.146
P407
P577
2015-08-21T00:00:00Z